Air pollutants can cause or contribute to thedevelopment of respiratory illnesses (e.g. asthma), contribute to cardiovascular diseases and increase the risk of heart attacks. Chronic exposure increases the risk of death and reduces life expectancy, even at low concentrations. Air pollution is particularly harmful to the elderly, the sick, children and foetuses. Fine particulate matter (PM2.5) is used as an indicator of human health because it can penetrate directly into the human body, with clear health effects following both short- and long-term exposure.
The indicator shows the annual number of premature deaths attributable to exposure to fine particulate matter (PM2.5) pollution in Switzerland.
poor
positive
Although the death toll from PM2.5 pollution has fallen, there are still around 2,000 premature deaths each year. Given that this figure remains high, the status is assessed as poor.
Calculations based on the same methodological principles estimate the burden of disease caused by particulate matter for 2019 at around 3,500 new cases of chronic obstructive pulmonary disease (COPD), 5,600 new cases of dementia, 1,000 new cases of type 2 diabetes and 2,600 new cases of ischaemic heart disease, as well as 400 new cases of lung cancer. Furthermore, this results in approximately 2.5 million days of reduced activity among adults (Castro et al. 2023, available in german).
Progressively stricter air pollution control measures, particularly emission limits for transport, industry and heating systems, have significantly reduced particulate matter pollution in Switzerland. This reduction in particulate matter pollution is reflected in a decline in premature deaths caused by air pollution. This trend is therefore assessed as positive.
Like other European countries, Switzerland has recorded a decline in PM2.5-related deaths in recent years (see Premature deaths due to exposure to fine particulate matter in Europe).
The health impact assessment is based on a population-weighted PM2.5 exposure and an epidemiologically derived exposure-response relationship of 1.118 per 10 µg/m³ PM2.5 for disease-related mortality, as reported in an ELAPSE study conducted by Brunekreef and al. 2022). A threshold of 5 µg/m³ was applied in accordance with WHO air quality guidelines).
| Targeted trend | Initial value | Final value | Variation in % | Observed trend | Assessment |
|---|---|---|---|---|---|
| Decrease | Average 2000-2002 | Average 2022-2024 | -64.48% | Decrease | positive |